DekaBank Deutsche Girozentrale - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 95 filers reported holding ALBIREO PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q1 2023$1,987
+108.1%
45,0000.0%0.01%
+66.7%
Q4 2022$955
-99.9%
45,0000.0%0.00%
+50.0%
Q3 2022$823,000
+25.8%
45,000
+28.6%
0.00%0.0%
Q2 2022$654,000
-44.9%
35,000
+3.2%
0.00%
-33.3%
Q2 2021$1,186,000
+5.3%
33,9000.0%0.00%
-25.0%
Q1 2021$1,126,000
-10.2%
33,9000.0%0.00%
-20.0%
Q4 2020$1,254,000
+10.9%
33,900
-4.8%
0.01%0.0%
Q3 2020$1,131,00035,6000.01%
Other shareholders
ALBIREO PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Prosight Management, LP 270,146$6,627,0003.42%
Perceptive Advisors 1,704,330$39,506,0001.50%
Birchview Capital, LP 38,000$932,0000.88%
SECTORAL ASSET MANAGEMENT INC 229,978$5,641,0000.77%
BVF INC/IL 200,500$4,918,0000.64%
Artal Group S.A. 500,000$12,265,0000.45%
PA Capital LLC 14,692$360,0000.38%
Chicago Capital, LLC 180,911$4,438,0000.36%
TPG Group Holdings (SBS) Advisors, Inc. 716,381$17,573,0000.28%
Fosun International Ltd 197,005$4,492,0000.27%
View complete list of ALBIREO PHARMA INC shareholders